DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Compare

521 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

XRAY Analyst Ratings

Hold

3 Buy

9 Hold

0 Sell

Based on 12 analysts giving stock ratings to

DENTSPLY

SIRONA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

XRAY Stock 12 Month Forecast

Average Price Target

$17.75

▲(11.42%Upside)

Based on 12 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $17.75 with a high forecast of $25.00 and a low forecast of $14.00. The average price target represents a 11.42% change from the last price of $15.93.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","27":"$27","15.75":"$15.75","19.5":"$19.5","23.25":"$23.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$17.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15.75,19.5,23.25,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.46,16.193846153846156,16.927692307692308,17.661538461538463,18.395384615384614,19.12923076923077,19.863076923076925,20.596923076923076,21.33076923076923,22.064615384615387,22.798461538461538,23.532307692307693,24.26615384615385,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.46,15.636153846153848,15.812307692307693,15.98846153846154,16.164615384615384,16.340769230769233,16.516923076923078,16.693076923076923,16.869230769230768,17.045384615384616,17.22153846153846,17.397692307692306,17.573846153846155,{"y":17.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.46,15.34769230769231,15.235384615384616,15.123076923076924,15.010769230769231,14.89846153846154,14.786153846153846,14.673846153846155,14.561538461538461,14.44923076923077,14.336923076923076,14.224615384615385,14.112307692307692,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.88,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.79,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.82,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.42,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.38,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.82,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.26,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.6,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.22,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.79,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.46,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$25.00

Average Price Target$17.75

Lowest Price Target$14.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$17

Hold

6.72%

Upside

Reiterated

06/26/25

The overall stock score reflects a challenging financial performance with declining revenues and profitability, but is supported by positive technical indicators and strategic corporate actions. While valuation remains a concern due to negative earnings, the dividend yield and successful debt management provide some reassurance. Corporate events, such as the appointment of a new CFO, signal potential for future improvement.

Vik ChopraWells Fargo

Wells Fargo

$16

Hold

0.44%

Upside

Reiterated

06/18/25

Analysts' Top Healthcare Picks: Zoetis (ZTS), DENTSPLY SIRONA (XRAY)

Michael ChernyLeerink Partners

Leerink Partners

$14.5→$16.5

Hold

3.58%

Upside

Reiterated

06/17/25

Cautious Outlook on DENTSPLY SIRONA Amid Strategic Focus and Market Challenges

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$17

Hold

6.72%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Evercore ISI

Jason BednarPiper Sandler

Piper Sandler

$16→$17

Hold

6.72%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Piper Sandler

Allen LutzBank of America Securities

Bank of America Securities

$17

Hold

6.72%

Upside

Reiterated

05/29/25

Hold Rating on DENTSPLY SIRONA Amid Management Stabilization and Growth Uncertainties

Michael PetuskyBarrington

Barrington

$20→$21

Buy

31.83%

Upside

Reiterated

05/12/25

Dentsply Sirona price target raised to $21 from $20 at BarringtonDentsply Sirona price target raised to $21 from $20 at Barrington

Kevin CaliendoUBS

UBS

$27→$25

Buy

56.94%

Upside

Reiterated

05/09/25

Dentsply Sirona price target lowered to $25 from $27 at UBSDentsply Sirona price target lowered to $25 from $27 at UBS

Steven ValiquetteMizuho Securities

Mizuho Securities

$16→$17

Hold

6.72%

Upside

Reiterated

05/09/25

DENTSPLY SIRONA (XRAY) PT Raised to $17 at MizuhoMizuho analyst Steven Valiquette raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $16.00) while maintaining a Neutral rating.

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$20→$17

Hold

6.72%

Upside

Reiterated

05/09/25

DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JPMorganJPMorgan analyst Tycho Peterson lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Neutral rating.

Erin WrightMorgan Stanley

Morgan Stanley

$14

Hold

-12.12%

Downside

Reiterated

05/08/25

DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

05/08/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/08/25

DENTSPLY SIRONA: Hold Rating Amid Strong Performance and CFO Uncertainty

Glen SantangeloJefferies

Jefferies

$20→$17

Hold

6.72%

Upside

Reiterated

03/06/25

DENTSPLY SIRONA (XRAY) PT Lowered to $17 at JefferiesJefferies analyst Brandon Couillard lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $20.00) while maintaining a Hold rating.

Jeff JohnsonRobert W. Baird

Robert W. Baird

$22→$20

Hold

25.55%

Upside

Reiterated

02/28/25

Dentsply Sirona price target lowered to $20 from $22 at BairdDentsply Sirona price target lowered to $20 from $22 at Baird

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$17

Hold

6.72%

Upside

Reiterated

06/26/25

Vik ChopraWells Fargo

Wells Fargo

$16

Hold

0.44%

Upside

Reiterated

06/18/25

Analysts' Top Healthcare Picks: Zoetis (ZTS), DENTSPLY SIRONA (XRAY)

Michael ChernyLeerink Partners

Leerink Partners

$14.5→$16.5

Hold

3.58%

Upside

Reiterated

06/17/25

Cautious Outlook on DENTSPLY SIRONA Amid Strategic Focus and Market Challenges

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$17

Hold

6.72%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Evercore ISI

Jason BednarPiper Sandler

Piper Sandler

$16→$17

Hold

6.72%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Piper Sandler

Allen LutzBank of America Securities

Bank of America Securities

$17

Hold

6.72%

Upside

Reiterated

05/29/25

Hold Rating on DENTSPLY SIRONA Amid Management Stabilization and Growth Uncertainties

Michael PetuskyBarrington

Barrington

$20→$21

Buy

31.83%

Upside

Reiterated

05/12/25

Dentsply Sirona price target raised to $21 from $20 at BarringtonDentsply Sirona price target raised to $21 from $20 at Barrington

Kevin CaliendoUBS

UBS

$27→$25

Buy

56.94%

Upside

Reiterated

05/09/25

Dentsply Sirona price target lowered to $25 from $27 at UBSDentsply Sirona price target lowered to $25 from $27 at UBS

Steven ValiquetteMizuho Securities

Mizuho Securities

$16→$17

Hold

6.72%

Upside

Reiterated

05/09/25

DENTSPLY SIRONA (XRAY) PT Raised to $17 at MizuhoMizuho analyst Steven Valiquette raised the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $17.00 (from $16.00) while maintaining a Neutral rating.

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$20→$17

Hold

6.72%

Upside

Reiterated

05/09/25

Erin WrightMorgan Stanley

Morgan Stanley

$14

Hold

-12.12%

Downside

Reiterated

05/08/25

DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

05/08/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/08/25

DENTSPLY SIRONA: Hold Rating Amid Strong Performance and CFO Uncertainty

Glen SantangeloJefferies

Jefferies

$20→$17

Hold

6.72%

Upside

Reiterated

03/06/25

Jeff JohnsonRobert W. Baird

Robert W. Baird

$22→$20

Hold

25.55%

Upside

Reiterated

02/28/25

Dentsply Sirona price target lowered to $20 from $22 at BairdDentsply Sirona price target lowered to $20 from $22 at Baird

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

1 Month

xxx

Success Rate

14/35 ratings generated profit

Average Return

-2.52%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of -2.52% per trade.

3 Months

xxx

Success Rate

10/35 ratings generated profit

Average Return

-5.49%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -5.49% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

4/35 ratings generated profit

Average Return

-22.48%

reiterated a buy rating 2 months ago

Copying Michael Petusky's trades and holding each position for 1 Year would result in 11.43% of your transactions generating a profit, with an average return of -22.48% per trade.

2 Years

xxx

Success Rate

1/35 ratings generated profit

Average Return

-32.88%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 2.86% of your transactions generating a profit, with an average return of -32.88% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XRAY Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, XRAY has received 3 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. XRAY average Analyst price target in the past 3 months is 17.75.

Each month's total comprises the sum of three months' worth of ratings.

XRAY Financial Forecast

XRAY Earnings Forecast

Next quarter’s earnings estimate for XRAY is $0.50 with a range of $0.46 to $0.55. The previous quarter’s EPS was $0.43. XRAY beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.16% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Sales Forecast

Next quarter’s sales forecast for XRAY is $930.50M with a range of $911.20M to $952.00M. The previous quarter’s sales results were $879.00M. XRAY beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Stock Forecast FAQ

What is XRAY’s average 12-month price target, according to analysts?

Based on analyst ratings, DENTSPLY SIRONA’s 12-month average price target is 17.75.

What is XRAY’s upside potential, based on the analysts’ average price target?

DENTSPLY SIRONA has 11.42% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is XRAY a Buy, Sell or Hold?

DENTSPLY SIRONA has a consensus rating of Hold which is based on 3 buy ratings, 9 hold ratings and 0 sell ratings.

What is DENTSPLY SIRONA’s price target?

The average price target for DENTSPLY SIRONA is 17.75. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $14.00. The average price target represents 11.42% Increase from the current price of $15.93.

What do analysts say about DENTSPLY SIRONA?

DENTSPLY SIRONA’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of XRAY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

XRAY Analyst Ratings

XRAY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering DENTSPLY SIRONA

XRAY Analyst Recommendation Trends

XRAY Financial Forecast

XRAY Earnings Forecast

XRAY Sales Forecast

XRAY Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts